tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Apple, Intel little changed near noon following earnings: Morning Buzz
The FlyApple, Intel little changed near noon following earnings: Morning Buzz
2d ago
V
Z
Vertex Pharmaceuticals price target raised to $545 from $520 at BMO Capital
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $545 from $520 at BMO Capital
2d ago
VRTX
Early notable gainers among liquid option names on January 31st
PremiumThe Fly
Early notable gainers among liquid option names on January 31st
2d ago
BKR
EMN
Vertex Pharmaceuticals price target raised to $433 from $430 at Scotiabank
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $433 from $430 at Scotiabank
2d ago
VRTX
Vertex Pharmaceuticals price target raised to $550 from $535 at H.C. Wainwright
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $550 from $535 at H.C. Wainwright
2d ago
VRTX
Vertex Pharmaceuticals price target lowered to $320 from $325 at Baird
PremiumThe FlyVertex Pharmaceuticals price target lowered to $320 from $325 at Baird
2d ago
VRTX
Vertex Pharmaceuticals price target raised to $435 from $418 at Barclays
Premium
The Fly
Vertex Pharmaceuticals price target raised to $435 from $418 at Barclays
2d ago
VRTX
Vertex Pharmaceuticals announces Casgevy reimbursement pact with NHS England
Premium
The Fly
Vertex Pharmaceuticals announces Casgevy reimbursement pact with NHS England
2d ago
VRTX
Closing Bell Movers: Atlassian up 19%, Apple gains 3% after results
PremiumThe Fly
Closing Bell Movers: Atlassian up 19%, Apple gains 3% after results
3d ago
V
AJG
Vertex Pharmaceuticals announces FDA approval of Journavx
PremiumThe Fly
Vertex Pharmaceuticals announces FDA approval of Journavx
3d ago
VRTX
Vertex Pharmaceuticals up 2% at $448 after FDA Journavx approval
PremiumThe Fly
Vertex Pharmaceuticals up 2% at $448 after FDA Journavx approval
3d ago
VRTX
Vertex Pharmaceuticals’ non-opioid painkiller approved by FDA, Bloomberg says
PremiumThe Fly
Vertex Pharmaceuticals’ non-opioid painkiller approved by FDA, Bloomberg says
3d ago
VRTX
Vertex Pharmaceuticals’ non-opioid Journavx approved for pain by FDA
PremiumThe FlyVertex Pharmaceuticals’ non-opioid Journavx approved for pain by FDA
3d ago
VRTX
Meta Platforms, CVS Health upgraded: Wall Street’s top analyst calls
Premium
The Fly
Meta Platforms, CVS Health upgraded: Wall Street’s top analyst calls
3d ago
BL
KO
Wells downgrades Vertex to Equal Weight on lack of catalysts
Premium
The Fly
Wells downgrades Vertex to Equal Weight on lack of catalysts
3d ago
LLY
ABBV
Vertex downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe Fly
Vertex downgraded to Equal Weight from Overweight at Wells Fargo
3d ago
VRTX
Vertex Pharmaceuticals price target lowered to $533 from $535 at Piper Sandler
PremiumThe Fly
Vertex Pharmaceuticals price target lowered to $533 from $535 at Piper Sandler
6d ago
VRTX
Vertex Pharmaceuticals price target lowered to $450 from $456 at Morgan Stanley
PremiumThe Fly
Vertex Pharmaceuticals price target lowered to $450 from $456 at Morgan Stanley
6d ago
VRTX
Vertex a ‘core large-cap biotech holding,’ says JPMorgan
PremiumThe Fly
Vertex a ‘core large-cap biotech holding,’ says JPMorgan
20d ago
VRTX
Vertex Pharmaceuticals price target lowered to $456 from $476 at Morgan Stanley
PremiumThe FlyVertex Pharmaceuticals price target lowered to $456 from $476 at Morgan Stanley
23d ago
VRTX
Zai Lab, Vertex Pharmaceuticals announce povetacicept license agreement
Premium
The Fly
Zai Lab, Vertex Pharmaceuticals announce povetacicept license agreement
23d ago
VRTX
ZLAB
Vertex Pharmaceuticals, Orna Therapeutics announce research collaboration
Premium
The Fly
Vertex Pharmaceuticals, Orna Therapeutics announce research collaboration
26d ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >